Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes

Cell Death Dis. 2018 May 1;9(5):526. doi: 10.1038/s41419-018-0600-3.

Abstract

Somatic cells acquire stem cell-like properties during cancerous transformation; however, mechanisms through which committed cells develop stemness and malignancy remain largely unknown. Here we uncovered upregulated stem cell program in leukaemic lymphoblasts of patients with IKZF1 alterations by analysing the archived gene-expression profiling datasets. We then used a frequent IKZF1 deletion, IK6, as a model via transduction into human primitive haematopoietic cells, followed by xenotransplantation in mice. Immunophenotypically defined stem, pro-B, and immature/mature (IM/M)-B cells were collected from primary recipients for functional assay and transcriptome profiling. Successful reconstitution in secondary recipient mice revealed the stemness of IK6+ pro-B and IM/M-B cells. Upregulated stemness and malignancy programs in IK6+ cells confirmed IK6 effects. Interestingly, these programs corresponded to distinct canonical pathways. Remarkably, the pathway profile mapped in the modelled cells well mirrored that in patients' leukaemic cells; therefore, our study provides a seminal insight into the cancerous reprogramming of somatic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Ikaros Transcription Factor* / genetics
  • Ikaros Transcription Factor* / metabolism
  • Leukemia* / genetics
  • Leukemia* / metabolism
  • Leukemia* / pathology
  • Lymphocytes / metabolism*
  • Lymphocytes / pathology
  • Mice, Inbred NOD
  • Mice, SCID
  • Neoplasm Proteins* / genetics
  • Neoplasm Proteins* / metabolism
  • Neoplastic Stem Cells / metabolism*
  • Neoplastic Stem Cells / pathology

Substances

  • IKZF1 protein, human
  • Neoplasm Proteins
  • Ikaros Transcription Factor